MedifastFRA:MDF -7.25%70 Days Payable is 99.82 as of Mar. 2026, which is 91% above its 10-year median of 52.34. GuruFocus rates FRA:MDF with a GF Score™ of 70/100 and a GF Value™ of €7.03 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 91 Personal Services companies, Medifast ranks better than 82.42% on this metric.
Medifast's average Accounts Payable for the
three
months ended in Mar. 2026 was €23.0 Mil. Medifast's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €21.0 Mil.
Hence, Medifast's Days Payable for the
three
months ended in Mar. 2026 was 99.82.
The historical rank and industry rank for Medifast's Days Payable or its related term are showing as below:
FRA:MDF'
s Days Payable Range Over the Past 10 Years
Min: 42.96 Med: 52.34 Max: 131.77
Current: 131.77
During the past 13 years, Medifast's highest Days Payable was 131.77. The lowest was 42.96. And the median was 52.34.
FRA:MDF's Days Payable is ranked better than 82.42% of 91
companies
in the Personal Services industry
Industry Median: 32.93
vs FRA:MDF: 131.77
Medifast's Days Payable
declined
from Mar. 2025 (109.58) to Mar. 2026 (99.82).
It may suggest that Medifastaccelerated paying its suppliers.
Medifast Days Payable Related Terms
Medifast Days Payable Historical Data
* Premium members only.
The historical data trend for Medifast's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MDF vs RGS, VGES, EVTK: Days Payable Comparison
For the Personal Services subindustry, Medifast's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast Days Payable vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's Days Payable distribution charts can be found below:
* The bar in red indicates where Medifast's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medifast's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (FRA:MDF) has a Days Payable of 99.82 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medifast and its competitors. This is 91% above median its historical median of 52.34. Over the past decade, Medifast's Days Payable has ranged from 42.96 to 131.77. According to the industry distribution chart, Medifast ranks #16 out of 91 companies in the Personal Services industry, placing it in the top 17.6%.
Is Medifast's Days Payable too high?
Medifast's current Days Payable of 99.82 is 91% above median its 10-year median of 52.34. Over the past 10 years, this metric has ranged from a low of 42.96 to a high of 131.77. The Personal Services industry median Days Payable is 32.93. Medifast's value of 99.82 is 203.1% above this industry median. Based on the distribution chart, Medifast ranks #16 out of 91 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medifast has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Days Payable compare to RGS and VGES?
According to the Personal Services industry distribution chart, Medifast ranks #16 out of 91 companies for Days Payable. This places Medifast in the top 18% of its industry — outperforming the majority of peers. The industry median Days Payable is 32.93. Medifast's value of 99.82 is 203.1% above this benchmark. Historically, Medifast's own Days Payable has ranged from 42.96 to 131.77 over the past decade. While the company's 10-year median is 52.34 vs. the industry median of 32.93, Medifast has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Personal Services company?
The median Days Payable among Personal Services companies is 32.93, based on 91 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medifast's current Days Payable of 99.82 is 203.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medifast and its competitors. For the Personal Services industry, the median Days Payable is 32.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current Days Payable is 99.82, which is 91% above median its own 10-year median of 52.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (FRA:MDF) is currently considered Modestly Overvalued. The stock's GF Value™ is €7.03, compared to a current price of €8.44 — trading 20.1% above its estimated fair value. The current Days Payable is 99.82, which is 91% above median its 10-year median of 52.34 and 203.1% above the Personal Services industry median of 32.93. Medifast's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medifast (FRA:MDF), the current Days Payable is 99.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (FRA:MDF) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of €8.44 is trading 20.1% above its estimated GF Value™ of €7.03.
GuruFocus considers Medifast to be Modestly Overvalued.
Key valuation signals for FRA:MDF:
Days Payable: 99.82 (91% above median its 10-year median of 52.34)
GF Value™: €7.03 vs. price of €8.44 (20.1% above fair value)
Industry Position: 203.1% above the Personal Services median (#16 of 91)
No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
70GF Score
Get the complete analysis for FRA:MDF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MDF has been successfully added to your 
